• CD3 and VIB enter into an exclusive license and research collaboration with SpringWorks Therapeutics to develop TEAD inhibitors for addressing biomarker-defined cancers

    Friday May 7th 2021

  • Biocartis announces new collaboration with AstraZeneca to expand availability of Idylla™ EGFR biomarker testing among patients with lung cancer

    Wednesday May 5th 2021

  • Precirix partners with Evergreen to expand North American clinical trial supply

    Wednesday April 28th 2021

  • Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies

    Friday April 23rd 2021

  • Biocartis and SkylineDx sign collaboration to develop the Merlin Assay

    Thursday April 22nd 2021

  • Antelope DX to join forces with In The Pocket and Extra Horizon for the development of its easy-to-use, high-quality home testing device

    Friday April 16th 2021

  • Consortium led by eTheRNA immunotherapies awarded EU Commission TIGER Grant of EUR 6.9 million

    Sunday March 21st 2021

  • European Centre for Disease Prevention and Control (ECDC) intensifies the identification and tracking of mutations of the SARSCoV-2 genome across Europe with support of Eurofins Genomics

    Friday February 26th 2021

  • Your news here?

  • From SIMPLER cohorts, Eurofins Genomics successfully extracted 38.000 samples and run 40.500 samples on GWAS microarray during a one-year period.

    Monday February 15th 2021

  • Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

    Thursday January 14th 2021

  • argenx and Zai Lab announce strategic collaboration for Efgartigimod in Greater China

    Thursday January 7th 2021


Strategic Partners